EAM Investors’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | – | Sell |
-58,619
| Closed | -$2.19M | – | 438 |
|
2021
Q2 | $2.19M | Buy |
+58,619
| New | +$2.19M | 0.34% | 107 |
|
2020
Q3 | – | Sell |
-38,983
| Closed | -$990K | – | 383 |
|
2020
Q2 | $990K | Sell |
38,983
-29,932
| -43% | -$760K | 0.22% | 193 |
|
2020
Q1 | $1.27M | Sell |
68,915
-102,173
| -60% | -$1.88M | 0.39% | 121 |
|
2019
Q4 | $3.77M | Buy |
+171,088
| New | +$3.77M | 0.83% | 15 |
|
2019
Q1 | – | Sell |
-35,673
| Closed | -$381K | – | 346 |
|
2018
Q4 | $381K | Sell |
35,673
-11,613
| -25% | -$124K | 0.1% | 247 |
|
2018
Q3 | $722K | Hold |
47,286
| – | – | 0.11% | 269 |
|
2018
Q2 | $579K | Hold |
47,286
| – | – | 0.09% | 274 |
|
2018
Q1 | $452K | Sell |
47,286
-17,054
| -27% | -$163K | 0.08% | 279 |
|
2017
Q4 | $581K | Buy |
+64,340
| New | +$581K | 0.1% | 281 |
|